Back to Stonepine Capital Management, LLC

Stonepine Capital Management, LLC

All holdings · as of Dec 31, 2025

61 positions

CompanyClassValueShares% of portfolio
Verastem, Inc.$21.09M2,732,07916.7%
ADMA Biologics Inc$13.50M740,00010.7%
Evolus, Inc.$10.85M1,631,5888.6%
ZEVRA THERAPEUTICS, INC.$5.10M569,0884.0%
Inhibikase Therapeutics, Inc.$4.81M2,348,1473.8%
ABEONA THERAPEUTICS INC.$3.74M709,5053.0%
NEKTAR THERAPEUTICS$3.59M85,0002.8%
INDIVIOR PLC$3.59M100,0002.8%
Corbus Pharmaceuticals Holdings, Inc.CRBPCommon Stock$3.17M389,9162.5%
KAZIA THERAPEUTICS LTDKZIAADR$3.17M460,3592.5%
XOMA Royalty Corp$3.06M115,0002.4%
Verrica Pharmaceuticals Inc.VRCACommon Stock$2.94M353,6692.3%
Cybin Inc.$2.78M339,9022.2%
TELA Bio, Inc.$2.78M2,352,0322.2%
ACADIA Pharmaceuticals Inc$2.67M100,0002.1%
Surrozen, Inc./DESRZNCommon Stock$2.57M113,6312.0%
X4 Pharmaceuticals, Inc$2.37M593,5731.9%
AYTU BIOPHARMA INC$2.12M813,7041.7%
Day One Biopharmaceuticals, Inc.$1.86M200,0001.5%
Adicet Bio, Inc.$1.85M220,0111.5%
SPRUCE BIOSCIENCES, INC.SPRBCommon Stock$1.72M19,7421.4%
HERON THERAPEUTICS, INC. /DE$1.61M1,237,8021.3%
ENANTA PHARMACEUTICALS INC$1.58M100,0001.2%
PMV Pharmaceuticals, Inc.PMVPCommon Stock$1.44M1,150,7591.1%
Camp4 Therapeutics Corp$1.40M228,8941.1%
Eledon Pharmaceuticals, Inc.$1.35M893,1001.1%
Milestone Pharmaceuticals Inc.$1.34M662,6661.1%
OmniAb, Inc.OABICommon Stock$1.30M701,0001.0%
Quoin Pharmaceuticals Ltd.$1.13M78,1890.9%
Pulmonx Corp$1.07M486,4000.9%
GERON CORP$1.06M805,8000.8%
CRESCENT BIOPHARMA, INC.$1.04M87,6820.8%
KEZAR LIFE SCIENCES INC$982.4K156,1790.8%
Edesa Biotech, Inc.$976.3K687,5000.8%
Boundless Bio, Inc.$852.1K710,0710.7%
RADIOPHARM THERANOSTICS LIMITEDRADXADR$850.9K51,000,0000.7%
Semler Scientific, Inc.$764.5K50,0000.6%
MAXCYTE, INC.$727.0K469,0180.6%
AN2 Therapeutics, Inc.$715.5K627,6680.6%
Gossamer Bio, Inc.$634.8K204,7700.5%
Zentalis Pharmaceuticals, Inc.ZNTLCommon Stock$626.0K463,7000.5%
BioAge Labs, Inc.BIOACommon Stock$595.4K45,0000.5%
MANNKIND CORP$489.7K86,3590.4%
COMPUGEN LTD$467.3K305,4000.4%
Codexis, Inc.$417.5K256,1060.3%
IN8bio, Inc.INABCommon Stock$385.9K164,8930.3%
FENNEC PHARMACEUTICALS INC.$385.0K50,0000.3%
Cabaletta Bio, Inc.$374.7K171,1000.3%
Pasithea Therapeutics Corp.KTTACommon Stock$354.8K275,0620.3%
PLIANT THERAPEUTICS, INC.PLRXCommon Stock$280.7K230,0500.2%
← PrevPage 1 of 2Next →